Financing type:  bought deal prospectus offering

Gross proceeds:  $30,504,000

Offering:  5,084,000 listed shares

Offering price:  $6 per listed share

Overallotment option:  The underwriters may purchase a maximum of 762,600 listed shares for overallotment purposes, at any time until 30 days following the closing date. As of April 15, 2026, such option was not exercised.

Disclosure:  Refer to the prospectus dated Feb. 23, 2026, and the company's news releases dated Feb. 10, 2026, Feb. 11, 2026, Feb. 24, 2026, and Feb. 27, 2026.